공식 의료 및 학교 정책이에요 — 나라별로. 출처를 보려면 클릭하세요.
2026
Albania’s deputy minister said the 2026 hormone guidance is for adults only.
공식 출처
Deputy minister — 2026 hormone guidance is adults-only.
전체 업데이트 읽기 →
2025
Andorra funds hormones from 16 and surgery from 18 — under-16s get assessment, not funded hormones.
공식 출처
Restricted: Decree 298/2025 public-financing rules — hormones from 16, surgery from 18; under-16s get specialist follow-up.
전체 업데이트 읽기 →
2026
지금은 데이터가 없어요. 공식 업데이트가 있으면 연락으로 이메일을 보내 주세요.
전체 업데이트 읽기 →
2015
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2026
지금은 데이터가 없어요. 공식 업데이트가 있으면 연락으로 이메일을 보내 주세요.
전체 업데이트 읽기 →
2010–2025
Belarus only runs official sex-change/correction for adults in state facilities.
공식 출처
Restricted: MoH Resolution 163 (9 December 2010, as amended) is an adult-only state pathway — hormones and/or surgery after an interdepartmental commission. Not an all-ages prohibition like Russia 386-FZ.
전체 업데이트 읽기 →
2023–2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2024
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2016
Croatia’s 2016 ministry guidelines allow puberty blockers from early puberty (Tanner stage 2).
공식 출처
Ministry of Health expert guidelines (NN 7/2016) set the WPATH (the World Professional Association for Transgender Health)-aligned pathway, including hormones for people with gender dysphoria.
전체 업데이트 읽기 →
2010–2022
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2025
A 2025 health-ministry methodology covers gender-incongruence care, including before 18.
공식 출처
MoH Metodický pokyn (1 July 2025) standardises legal-sex-change certificates; care may start before 18.
전체 업데이트 읽기 →
2023
Denmark is tightening clinical guidance on puberty blockers; there is no legislative ban.
공식 출처
Restricted: Sundhedsstyrelsen is revising 2018 clinical guidance toward psychosocial support first — a clinical limit, not a legislative ban.
전체 업데이트 읽기 →
2023–2025
The Social Ministry–funded hormone guideline requires adulthood before opposite-sex hormones.
공식 출처
Restricted: the Social Affairs Ministry-funded hormone guideline requires adulthood (täisealisus) before hormones for sex-rejecting procedures.
전체 업데이트 읽기 →
2020
Finland puts talk therapy first. Hormones for minors, if used, are exceptional.
공식 출처
Restricted: COHERE recommends psychosocial support first; hormone treatment, where used, is centralized and exceptional.
전체 업데이트 읽기 →
2022
France’s medical academy urged great caution.
공식 출처
Mixed: the National Academy of Medicine called for the greatest medical reserve.
전체 업데이트 읽기 →
2024
Georgia forbids surgery or other medical manipulation to assign a sex different from biological sex, for people of any age.
공식 출처
Officially banned: Family Values law Article 6 forbids surgery or other medical manipulation to assign a different sex (all ages). Not the U.S. state. Art. 6 has no carve-out that leaves puberty blockers legal.
전체 업데이트 읽기 →
2025
Germany still allows puberty blockers after strict criteria.
공식 출처
Mixed: the 2025 AWMF S2k guideline still permits puberty blockers after Tanner 2 under criteria.
전체 업데이트 읽기 →
2017–2021
Law 4491/2017 lets a person from age 15 change the registered sex after an interdisciplinary medical committee.
공식 출처
Law 4491/2017 lets a person from 15 correct the registered sex marker after an interdisciplinary medical committee.
전체 업데이트 읽기 →
2021
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2019–2020
Iceland’s public pathway can refer under-18s for hormones; permanent genital surgery under 16 is excluded.
공식 출처
Gender Autonomy Act; public pathway can refer under-18s for hormones; under-16 permanent genital changes need a physical-health reason.
전체 업데이트 읽기 →
2025
Ireland’s health service is writing a new model of care.
공식 출처
Under review: the HSE is producing a new Model of Care and reviewing the evidence.
전체 업데이트 읽기 →
2024
Italy’s bioethics committee said the evidence on puberty blockers for minors is too weak.
공식 출처
Restricted: CNB (22 Nov 2024, published Dec 2024) found evidence for triptorelin in minors with gender dysphoria insufficient; urged Ministry-funded independent trials and hoped prescriptions would sit within those trials.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2013–2024
Latvia does not perform surgical sex-change on minors.
공식 출처
Civil-registry sex-marker change requires a medical certificate of sex change. The national children’s hospital has documented puberty blockers for diagnosed adolescents.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2022–2024
Lithuania’s health-ministry protocol covers diagnosis and hormone treatment for adults only.
공식 출처
MoH Order V-1307 (4 August 2022) is an adults-only diagnosis and hormone-treatment pathway.
전체 업데이트 읽기 →
1978–2016
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2018
Malta’s public pathway includes hormones.
공식 출처
LN 44/2018 put gender-identity conditions on the NHS schedule; the public pathway includes hormones.
전체 업데이트 읽기 →
2022
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2026
The Health Council left puberty blockers and hormones available after assessment.
공식 출처
Health Council 30 June 2026 advice left puberty blockers and hormones available after assessment.
전체 업데이트 읽기 →
2013–2025
The health ministry’s 2013 guideline sets an official adult-framed pathway for hormones and surgery.
공식 출처
The 2013 Ministry of Health evidence-based-medicine guideline on transsexualism is official medical-pathway guidance, framed for adult sex-change treatment.
전체 업데이트 읽기 →
2023
A safety agency called puberty blockers and hormones experimental — a clinical limit, not a legislative ban.
공식 출처
Restricted: Ukom recommended treating puberty blockers and hormones as experimental; that is a patient-safety recommendation, not a legislative ban.
전체 업데이트 읽기 →
2025
Polish expert guidelines still endorse puberty blockers and hormones for assessed adolescents.
공식 출처
Endokrynologia Polska 2025 expert-panel guidelines set puberty suppression and hormones for adolescents after assessment.
전체 업데이트 읽기 →
2026
A bill would ban puberty blockers and hormones under 18 — parliament has not made it law.
공식 출처
Proposed bill: PL 479/XVII/1ª (generalidade 20 March 2026) would prohibit puberty blockers and hormones under 18.
전체 업데이트 읽기 →
2020
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2023
Russia banned medical interventions aimed at changing sex, with an exception for inborn sex-development conditions (DSD).
공식 출처
Officially banned: Federal Law 386-FZ (2023) prohibits medical interventions aimed at changing sex, with a congenital/DSD exception.
전체 업데이트 읽기 →
2026
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2024
Two NHS boards paused new puberty blockers and hormones for minors — existing patients were not taken off treatment.
공식 출처
Restricted: NHS Greater Glasgow and Clyde and NHS Lothian paused new puberty blocker and opposite-sex hormone prescriptions (April 2024).
전체 업데이트 읽기 →
2012–2021
The health-insurance fund’s sex-change brochure requires the person to be older than 18.
공식 출처
Restricted: RFZO’s published funded sex-change pathway starts at age 18.
전체 업데이트 읽기 →
2025
No official pediatric medical policy listed.
공식 출처
No official pediatric medical policy listed.
전체 업데이트 읽기 →
2022
Slovenia’s public gender-identity council includes child psychiatry and endocrinology.
공식 출처
The Advocate of the Principle of Equality’s 2022 special report documents medical confirmation and legal-sex-change procedures in force.
전체 업데이트 읽기 →
2026
A Valencian rule on puberty blockers for minors is in court.
공식 출처
Mixed: Valencia’s 2025 Ley 8/2017 amendments sit under Constitutional Court suspension.
전체 업데이트 읽기 →
2022
Sweden treats puberty blockers and hormones for adolescents as research, not standard care.
공식 출처
Restricted to research: Socialstyrelsen recommends puberty suppression and opposite-sex hormones for adolescents only in a research setting, not as standard care.
전체 업데이트 읽기 →
2024–2025
Zürich says puberty blockers stay available with specialist assessment.
공식 출처
NEK-CNE opinion 43/2024 describes puberty blockade as current practice; Zurich’s health directorate said access to puberty blockers is not being restricted.
전체 업데이트 읽기 →
2016
Ukraine’s health-ministry Order 972 is the clinical protocol for gender dysphoria, including hormones.
공식 출처
MoH Order 972 (15 September 2016) is the unified clinical protocol for gender dysphoria, including hormones. Child psychiatry is on the pathway.
전체 업데이트 읽기 →
2024
No statute bans this. Routine puberty blockers for under-18s stopped after Cass; a puberty blockers trial is ongoing.
공식 출처
Restricted: no statute bans this care. NHS England stopped routine puberty blockers for under-18s after Cass; the PATHWAYS puberty blockers trial is ongoing.
전체 업데이트 읽기 →
2024
Holy See teaching in Dignitas Infinita rejects gender theory and sex-change interventions.
공식 출처
Restricted: Dignitas Infinita §§55–60 rejects gender theory and sex-change interventions. Disorders of sex development (DSD) correction is named separately.
전체 업데이트 읽기 →